Doxycycline

Chemical formula: C₂₂H₂₄N₂O₈  Molecular mass: 444.435 g/mol  PubChem compound: 54671203

Therapeutic indications

Doxycycline is indicated for:

Psittacosis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Ornithosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Brucellosis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Brucellosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Uncomplicated urethral, endocervical or rectal infection caused by Chlamydia trachomatis

Population group: only adults (18 years old or older)

at least one of
Chlamydia trachomatis urethritis
Infection of cervix caused by Chlamydia trachomatis
Chlamydia trachomatis infection of anus and rectum

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Tularaemia glanders

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Glandular tularemia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Nongonococcal urethritis caused by Ureaplasma urealyticum

Population group: only adults (18 years old or older)

Nongonococcal urethritis caused by Ureaplasma urealyticum

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Primary and secondary syphilis

Population group: only adults (18 years old or older)

at least one of
Primary syphilis
Secondary syphilis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute intestinal amoebiasis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute amebic rectocolitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Melioidosis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Infection due to Burkholderia pseudomallei

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Chloroquine-resistant falciparum malaria

Population group: only adults (18 years old or older)

Falciparum malaria

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylaxis of malaria

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Preventive procedure and additionally Malaria

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Cholera

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Cholera

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Tetanus

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Tetanus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of travellers' diarrhoea

Population group: only adults (18 years old or older)

Preventive procedure and additionally Traveler's diarrhea

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of leptospirosis

Population group: only adults (18 years old or older)

Preventive procedure and additionally Leptospirosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Leptospirosis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Leptospirosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Rocky Mountain spotted fever

Population group: only adults (18 years old or older)

RMSF - Rocky Mountain spotted fever

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of scrub typhus

Population group: only adults (18 years old or older)

Preventive procedure and additionally Scrub typhus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Louse and tick-borne relapsing fevers

Population group: only adults (18 years old or older)

at least one of
Louse-borne relapsing fever
Tick-borne relapsing fever

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acne vulgaris

Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Acne

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Uncomplicated gonococcal infections

Population group: only adults (18 years old or older)

Uncomplicated gonococcal infections (except anorectal infections in men).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute epididymo-orchitis caused by Chlamydia trachomatis or Neisseria gonorrhoea

Population group: only adults (18 years old or older)

Acute inflammation of testis and epididymis and additionally at least one of
Chlamydia trachomatis
Neisseria gonorrhoeae

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Respiratory tract infections, sinusitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Pneumonia and other lower respiratory tract infections due to susceptible strains of Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae and other organisms. Mycoplasma pneumoniae. Treatment of chronic bronchitis, sinusitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Urinary tract infections

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Urinary tract infections caused by susceptible strains of Klebsiella species, Enterobacter species, Escherichia coli, Streptococcus faecalis and other organisms.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Chancroid, granuloma inguinale, lymphogranuloma venereum

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Chancroid
Granuloma inguinale
Nicholas Favre disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Ophthalmic infections

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Ophthalmic infections due to susceptible strains of gonococci, staphylococci and Haemophilus influenzae.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Trachoma

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Trachoma, although the infectious agent, as judged by immunofluorescence, is not always eliminated.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Inclusion conjunctivitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Q fever

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Q fever

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bubonic plague

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Bubonic plague

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gas gangrene

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Gas gangrene

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Tetanus

Population group: only children (1 year - 12 years old)

Tetanus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gas gangrene

Population group: only children (1 year - 12 years old)

Gas gangrene

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Leptospirosis

Population group: only children (1 year - 12 years old)

Leptospirosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute intestinal amoebiasis

Population group: only children (1 year - 12 years old)

Acute amebic rectocolitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Melioidosis

Population group: only children (1 year - 12 years old)

Infection due to Burkholderia pseudomallei

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Tularaemia glanders

Population group: only children (1 year - 12 years old)

Glandular tularemia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bubonic plague

Population group: only children (1 year - 12 years old)

Bubonic plague

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Cholera

Population group: only children (1 year - 12 years old)

Cholera

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Brucellosis

Population group: only children (1 year - 12 years old)

Brucellosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Psittacosis

Population group: only children (1 year - 12 years old)

Ornithosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Q fever

Population group: only children (1 year - 12 years old)

Q fever

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Inclusion conjunctivitis

Population group: only children (1 year - 12 years old)

Inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Trachoma

Population group: only children (1 year - 12 years old)

Trachoma, although the infectious agent, as judged by immunofluorescence, is not always eliminated.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Ophthalmic infections

Population group: only children (1 year - 12 years old)

Ophthalmic infections due to susceptible strains of gonococci, staphylococci and Haemophilus influenzae.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Doxycycline is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: VIBRAMYCIN-D Dispersible Tablet
Structured Product Labeling (SPL) 2021: DOXY Powder for solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈